跳至主要内容
临床试验/NCT02139683
NCT02139683已完成不适用

High Intensity Focused Ultrasound for the Treatment of Fibroadenomata (HIFU-F)

Theraclion2 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2014年1月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
Theraclion
入组人数
50
试验地点
2
主要终点
Changes in size of fibroadenomata as recorded on ultrasound imaging

研究概览

简要总结

The purpose of this study is to assess the treatment of fibroadenomata with a circumferential sonification treatment with HIFU..

详细描述

Primary endpoint: fibroadenomata size reduction post-treatment on ultrasound imaging.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients >18 years of age
  • Fibroadenomata diagnosed according to local hospital protocol; ultrasound alone on patients <25 and ultrasound plus core-biopsy in patients >25 (Graded B2 or less)
  • Visible on ultrasound (Graded U2/U3)
  • Definitive diagnosis of fibroadenomata confirmed by the Breast multi-disciplinary team meeting (MDT).

排除标准

  • Lesion with atypia or suspicion of phyllodes (Graded B3 or greater)
  • Pregnant or lactating women
  • History of laser or radiation therapy to the targeted breast

研究组 & 干预措施

HIFU treatment

Experimental

HIFU treatment in patient diagnosed with fibroadenoma

干预措施: HIFU treatment (Device)

结局指标

主要结局

Changes in size of fibroadenomata as recorded on ultrasound imaging

时间窗: Month 1, Month 3, Month 12

次要结局

  • Patient recorded outcomes measures(Month 1, Month 3, Month 12)
  • Adverse Events(Month 1, Month 3, Month 12)
  • Mean treatment time(Treatment visit date)
  • Cost-effectiveness(12 months)

研究者

发起方
Theraclion
申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验